Direct costs of asthma in Brazil: A comparison between controlled and uncontrolled asthmatic patients

Brazilian Journal of Medical and Biological Research

Volumn 40, Issue 7, 2007, Pages 943-948

  Santos, L A ^a   Oliveira, M A ^a   Faresin, S M ^a   Santoro, I L ^a   Fernandes, A L G ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Asthma; Health care costs; Health care resources; Health economy

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; SHORT ACTING DRUG;

ADULT; AMBULATORY CARE; ARTICLE; ASTHMA; BRAZIL; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; HEALTH CARE COST; HEALTH CARE SYSTEM; HOSPITALIZATION; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PUBLIC HEALTH SERVICE; QUESTIONNAIRE; RESOURCE ALLOCATION; SYMPTOM;

EID: 34547728624     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2006005000129     Document Type: Article

References (25)

1. Williams H, Robertson C, Stewart A, Alt-Khaled N, Anabwani G, Anderson R, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International-Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999; 103: 125-138.
2. Neffen H, Fritscher C, Schacht FC, Levy G, Chiarella P, Soriano JB, et al. Asthma control in Latin America: the Asthma Insights and Reality in Latin America (AIRLA) survey. Rev Panam Salud Publica 2005; 17: 191-197.
3. Adachi M, Morikawa A, Ishihara K. Asthma insights and reality in Japan (AIRJ). Arerugi 2002; 51: 411-420.
4. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000; 16: 802-807.
5. The state of asthma in America. Two land mark surveys 1997-2006. www.asthmainamerica.com.
6. Lai CK, De Guia TS, Kim YY, Kuo SH, Mukhopadhyay A, Soriano JB, et al. Asthma control in the Asia-Pacific region: the Asthma Insights and Reality in Asia-Pacific Study. J Allergy Clin Immunol 2003; 111: 263-268.
7. Beasley R. The burden of asthma with specific reference to the United States. J Allergy Clin Immunol 2002; 109: S482-S489.
8. Gergen PJ. Understanding the economic burden of asthma. J Allergy Clin Immunol 2001; 107: S445-S448.
9. Barnes PJ, Jonsson B, Klim JB. The costs of asthma. Eur Respir J 1996; 9: 636-642.
10. Van Ganse E, Laforest L, Pietri G, Boissel JP, Gormand F, Ben-Joseph R, et al. Persistent asthma: disease control, resource utilisation and direct costs. Eur Respir J 2002; 20: 260-267.
11. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med 1992; 326: 862-866.
12. Smith DH, Malone DC, Lawson KA, Okamoto U, Battista C, Saunders WB. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med 1997; 156: 787-793.
13. Informações de Saúde. http://datasus.gov.br/tabnet/ tabnet.htm.
14. National Asthma Education and Prevention Program. Expert Panel Report, Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics 2002. J Allergy Clin Immunol 2002; 110: S141-S219.
15. Juniper EF, O'Byrne PM, Puyatt GH, Ferrie PJ, King DR. Development and validation of a questionaire to measure asthma control. Eur Respir J 1999; 14: 902-907.
16. Juniper, EF, Bousquet J, Apetz L, Bateman ED. Identifying 'well-controlled' and 'not well-controlled' asthma using-1he Asthma Control Questionnaire. Respir Med 2O06; 100: 616-621.
17. Informações de cambio online - Online exchange information. http://www.bcb.gov.br/.
18. Lista de preços atualizada. Rev Farm Kairos 2001; No. 13.
19. Sly RM. Decreases in asthma mortality in the United States. Ann Allergy Asthma Immunol 2000; 85: 121-127.
20. Sly RM. Association of decreases in asthma mortality with increases in sales of inhaled corticosteroids. J Allergy Clin Immunol 2000; 106: 782.
21. Goldman M, Rachmiel M, Gendler L, Katz Y. Decrease in asthma mortality rate in Israel from 1991-1995: is it related to increased use of inhaled corticosteroids? J Allergy Clin Immunol 2000; 105: 71-74.
22. de Oliveira MA, Faresin SM, Bruno VF, de Bittencourt AR, Fernandes AL. Evaluation of an educational programme for socially deprived asthma patients. Eur Respir J 1999; 14: 908-914.
23. de Oliveira MA, Muniz M, Santos L, Faresin SM, Fernandes AL. Custo efetividade de programs de educação para adultos asmáticos atendidos em hospital escola de instituição pública. J Pneumol 2002; 21: 71-76.
24. Marion RJ, Creer TL, Reynolds RV. Direct and indirect costs associated with the management of childhood asthma. Ann Allergy 1985; 54: 31-34.
25. Cisternas MG, Blanc PD, Yen IH, Katz PP, Earnest G, Eisner MD, et al. A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol 2003; 111: 1212-1218.